Short-term Outcomes after Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity

David K. Wallace, Raymond T. Kraker, Sharon F. Freedman, Eric R. Crouch, Amit R. Bhatt, M. Elizabeth Hartnett, Michael B. Yang, David L. Rogers, Amy K. Hutchinson, Deborah K. Vanderveen, Kathryn M. Haider, R. Michael Siatkowski, Trevano W. Dean, Roy W. Beck, Michael X. Repka, Lois E. Smith, William V. Good, Lingkun Kong, Susan A. Cotter, Jonathan M. Holmes